Our team of experienced engineers, scientists, analysts, and manufacturing staff have hands-on experience in a variety of modalities, platforms, and processes that are essential to the manufacturing of cell therapies.
BioCentriq internal teams work cross-functionally along with collaborating with our clients before, during, and after tech transfer activities for a smooth transition to GMP manufacturing.
Our expertise in process and analytical development, GMP readiness, clinical manufacturing and product release will get you, and your product, from concept to clinic successfully.
BioCentriq augments the client experience by harnessing a hybrid system, where we ensure the client is empowered to be on-site during activities in accordance with our person in plant procedures.
BioCentriq's Expertise Spans Multiple Domains
- NK (Natural Killer) Cells
- MSC (Mesenchymal stem cells)
- iPSC (Induced pluripotent stem cells)
- Epithelial Cells
- Extracellular Vesicles
- Cell Encapsulation Technologies
- CAR-T (Chimeric Antigen Receptor T-cells)
- TCR (T-cell Receptor) Engineered Therapies
- TILS (Tumor-infiltrating Lymphocytes)
- T-reg
- MSC (Mesenchymal stem cells)
- HSC (Hematopoietic Stem Cells)
- Dendritic Cells
- Cell Encapsulation Technologies
- Cell Count & Viability
- ELISA
- qPCR
- ddPCR
- Western Blot
- Flow Cytometry
- Potency/ Cytotoxicity
- Nutrient/Metabolite Analysis
We Apply Our Expertise in Several Ways
The BioCentriq Team
Depending on the approach and scope of your project, your team will include experts from process analytical development, MSAT, manufacturing and quality who have relevant expertise and experience.
In addition, a technical lead will be assigned who is familiar with your underlying technology or platform.
David Smith, Ph.D.
“I’ve been working in the biopharmaceutical industry for more than a decade and leverage my educational background in molecular biology and chemistry to take on process development, MSAT, and manufacturing roles in the CGT field. My goal is to apply my expertise to each project to help companies take their therapies from bench to clinic.”
Mary Loveras
Associate Director, MSAT
What's Unique About BioCentriq's Expertise?
Technology Agnostic With Emphasis on Cost-Effective Manufacturing